Related Experiment Video
Updated: Jun 5, 2026
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
The cardiorenal syndrome: a review
1Department of Cardiology, Wessex Cardiothoracic Centre, Southampton University Hospital, Southampton, UK.
Insights
Cardiorenal syndrome (CRS) involves heart and kidney dysfunction, impacting patient outcomes. Understanding its mechanisms and classification is key for effective management of this serious condition.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Cardiorenal syndrome (CRS) describes the complex interplay between cardiac and renal dysfunction.
- Both conditions significantly increase morbidity and mortality.
- Renal dysfunction is a strong predictor of adverse outcomes in heart failure patients.
Purpose of the Study:
- To review the epidemiology and classification of CRS.
- To explore the underlying pathophysiological mechanisms of cardiorenal dysfunction.
- To discuss current and future management strategies for CRS.
Main Methods:
- Literature review focusing on epidemiology, classification, pathophysiology, and management of CRS.
- Analysis of existing data on the prevalence and prognostic significance of cardiorenal interactions.
- Synthesis of information on diagnostic and therapeutic approaches.
Main Results:
- A proposed five-subtype classification system for CRS exists but is not yet widely adopted.
- Renal dysfunction is as significant a prognostic marker as ejection fraction in heart failure.
- Cardiovascular disease is highly prevalent in patients with renal failure.
Conclusions:
- Further research is needed to fully elucidate CRS pathophysiology.
- Standardization of classification and management strategies is crucial.
- Future directions involve improved diagnosis and integrated care for CRS patients.
Abstract:
Cardiorenal syndrome (CRS) is the umbrella term used to describe clinical conditions in which cardiac and renal dysfunctions coexist. Much has been written on this subject, but underlying pathophysiological mechanisms continue to be unravelled and implications for management continue to be debated. A classification system-incorporating five subtypes-has recently been proposed though it has yet to permeate into day-to-day clinical practice. CRS has garnered much attention from both the cardiological and nephrological communities since the condition is associated with significant morbidity and mortality. Renal dysfunction is highly prevalent amongst patients with heart failure and has been shown to be as powerful and independent a marker of adverse prognosis as ejection fraction. Similarly, patients with renal failure are considerably more likely to suffer cardiovascular disease than matched subjects from the general population. This paper begins by reviewing the epidemiology and classification of CRS before going on to consider the different pathological mechanisms underlying cardiorenal dysfunction. We then focus on management strategies and conclude by discussing future directions in the diagnosis and management of patients suffering with CRS.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
01:29Cardiomyopathy V: Interprofessional Care
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:29Hypertension II: Pathophysiology
01:22Heart Failure Drugs: Diuretics
01:29Acute Kidney Injury II: Pathophysiology